Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(21)02950-8
Abstract: Methods: This retrospective study used body weight data ≥100kg or body mass index (BMI) ≥30 to identify NVAF patients with obesity among dually enrolled Veterans Affairs (VA) and fee-for-service (FFS) Medicare patients. It evaluated risk…
read more here.
Keywords:
safety apixaban;
obese patients;
effectiveness safety;
apixaban versus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0041-1740254
Abstract: There has been limited evidence reported about the outcomes of oral anticoagulants among patients with venous thromboembolism (VTE) and chronic kidney disease (CKD), especially those with stage V/end-stage renal disease (ESRD). This retrospective cohort analysis…
read more here.
Keywords:
recurrent vte;
versus warfarin;
apixaban versus;
disease ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-059311
Abstract: Objectives To investigate effects of appropriately and inappropriately dosed apixaban/rivaroxaban versus warfarin on effectiveness and safety outcomes in patients with non-valvular atrial fibrillation (NVAF). Design Cohort study with nested case–control analyses using primary care electronic…
read more here.
Keywords:
apixaban versus;
versus warfarin;
rivaroxaban;
primary care ... See more keywords